Evaluation of Laboratory Findings of Patients With Coronavirus Disease 2019 in Kerman, Iran

Background objective: since december 2019 in wuhan, china there is a new form of pneumonia and after expansion in other countries, world health organization (who) called it coronavirus disease 2019 (covid-19). since the clinical laboratory findings have played an important role in the progression of the disease, this study aimed to evaluate the laboratory findings in covid-19 patients (before vaccination).methods: in this case-control study that was conducted from february to august 2020; the laboratory test status in 101 positive covid-19 patients was evaluated and compared with 101 healthy individuals.results: the results of our study showed that 21% of patients had low wbc, 24.75% low rbc, 37.62%, low hb, 18.81% with low hct, 29.7%, low plt, 41.58% had high pt, 71.29% high crp, 17.82% high urea, 11.88% high cr, 15.84% high ldh, 10.89% low sodium, 14.75% low potassium (k). the quantitative examination of blood factors showed that lymph%, mixed%, plt, hct, hb, and rbc were higher in the control group than in the case group. while neu%, wbc, ptt, crp, urea, ldh, k in the patient group were higher than in the control group.conclusion: according to the results of the study, it can be concluded that in the clinical treatment of covid-19 patients, much attention should be paid to the laboratory indicators to identify and intervene early in critically ill patients.